Therapy News and Research

RSS

HIV increases the prevalence of early menopause, shows study

Thanks to medical advancements, HIV-positive women now have a longer life expectancy, exposing them to numerous midlife health issues such as menopause.

6 Nov 2019

New therapy has potential to repair cells damaged by noise, prevent hearing loss

More than 700 million people worldwide suffer from some degree of hearing loss, including an estimated 20 percent of Americans over the age of 12, according to medical experts.

6 Nov 2019

Picky eaters and problem feeders benefit from the first Pediatric Feeding Group

Local children are learning how to enjoy eating during the first Pediatric Feeding Group at the Wichita State University Speech-Language-Hearing (SLH) Clinic.

6 Nov 2019

Study reveals key mechanism that helps cells to adapt to low-nutrient conditions

Scientists from the UNC School of Medicine and Stanford University have uncovered what may be a fundamental biological mechanism that helps organisms adapt to rapid changes to nutrients in their environments.

6 Nov 2019

Pioneering brain chip to fight opioid addiction: first US clinical test

Opioid addiction is among the biggest medical conditions troubling the U.S. today, and is far from reaching a solution. In 2017, it claimed almost 50 deaths per 100,000 in the state of West Virginia – the highest drug-overdose-related death rate in the US. Today, however, there is a gleam of hope from a new trial of an old technology to help fight this battle – a brain-embedded chip to counter opioid-induced cravings in treatment-refractory patients.

6 Nov 2019

New tool accurately predicts risks of death, complications from obesity and diabetes

A new web-based risk calculator can accurately predict the likelihood a patient with type 2 diabetes and obesity will die or develop serious complications including a heart attack, heart failure and diabetic kidney disease (nephropathy) within the next 10 years.

6 Nov 2019

UM launches CAR-T clinical trial for patients with myasthenia gravis

Neuromuscular experts with the University of Miami Health System and the Miller School of Medicine will launch a Phase 1/2 clinical trial (NCT04146051) using the CAR-T drug, Descartes-08, to treat patients with generalized myasthenia gravis.

5 Nov 2019

Bariatric surgery lowers diabetic kidney disease risk for severely obese teens with type 2 diabetes

Diabetic kidney disease is the leading cause of kidney failure in the nation, and its occurrence in youth with type 2 diabetes type 2 diabetes is rapidly rising.

5 Nov 2019

Teenage a time of sexual confusion, finds new study

During adolescence, in developed countries, sexual identity tends to become a matter of debate in about a fifth of people. A new study, published in the Journal of Adolescenceon November 3, 2019, shows that among children entering adolescence in a rural southern setting within the American culture, a sizable number of teenagers felt unsure at some point about which sex they were attracted to, and how they should describe their sexual orientation.

5 Nov 2019

Novel detection method for retinoblastoma

A retinoblastoma is a dangerous cancer often occurring in very young children, under 2, which can cause blindness or the loss of the eye. The tumor is a diffuse, gluey mass spread all over the eye. It also spreads easily. As a result of this, direct biopsy is impossible, unlike with most other tumors. Instead, eye examination by ophthalmologists (eye specialists) and ultrasound imaging are needed to make a diagnosis.

5 Nov 2019

Penn researchers tag CAR T cells with imaging markers to monitor cancer therapy

With CAR T cell therapy, a patient's own immune cells are genetically modified and inserted back into the body to find and kill cancer. This form of immunotherapy has already revolutionized some cancer treatments, but once the CAR T cells are inside a patient, where do they go? How do doctors know that they have successfully reached their target and that they are continuing to fight disease weeks, months, or even years later?

5 Nov 2019

Study identifies pretreatment change trajectories in people seeking treatment for AUD

Treatment for alcohol use disorder often involves a course of counseling aimed at changing the patient's drinking behavior.

5 Nov 2019

Study highlights role of mind-body therapies in addressing opioid-treated pain

A new study published Nov. 4, 2019, in the journal JAMA Internal Medicine details the first comprehensive look across the scientific literature at the role of mind-body therapies in addressing opioid-treated pain.

5 Nov 2019

Researchers identify potential drug targets for glioblastoma

Researchers at Karolinska Institutet in Sweden have identified 10 tumor-specific potential drug targets for the brain tumor glioblastoma. The results are presented in the scientific journal Cell Reports.

5 Nov 2019

Tumor cell plasticity counts during cancer metastasis

Cancer metastasis, which is the propagation of tumor cells into distant organs, is the leading cause of cancer patient mortality.

5 Nov 2019

HIMC at Mount Sinai to evaluate therapeutic effects of novel cancer immunotherapy

The Human Immune Monitoring Center at the Icahn School of Medicine at Mount Sinai will apply cutting-edge high-throughput technologies to evaluate the therapeutic effects of Libtayo (cemiplimab-rwlc), a PD-1 antibody blockade developed by biotechnology company Regeneron Pharmaceuticals, Inc and Sanofi.

5 Nov 2019

Dog ownership could lead to significant reduction in loneliness

A new University of Sydney trial lends weight to the expression 'man's best friend,' showing a sample of new dog owners saw a significant reduction in loneliness within three months of acquiring their pet.

5 Nov 2019

MD Anderson and Takeda announce agreement to develop off-the-shelf CAR NK-cell therapy platform

The University of Texas MD Anderson Cancer Center and Takeda Pharmaceutical Company Limited today announced an exclusive license agreement and research agreement to develop cord blood-derived chimeric antigen receptor-directed natural killer (CAR NK)-cell therapies, 'armored' with IL-15, for the treatment of B-cell malignancies and other cancers.

5 Nov 2019

FDA keeps brand-name drugs on a fast path to market ― despite manufacturing concerns

After unanimously voting to recommend a miraculous hepatitis C drug for approval in 2013, a panel of experts advising the Food and Drug Administration gushed about what they'd accomplished.

5 Nov 2019

Signs of frailty could be identified through a new assessment

Signs of frailty, and the risks it brings, could be identified in young and old people alike through a new assessment developed in a study led by researchers at the University of Strathclyde.

5 Nov 2019

Therapy News and Research

HIV increases the prevalence of early menopause, shows study

New therapy has potential to repair cells damaged by noise, prevent hearing loss

Picky eaters and problem feeders benefit from the first Pediatric Feeding Group

Study reveals key mechanism that helps cells to adapt to low-nutrient conditions

Pioneering brain chip to fight opioid addiction: first US clinical test

New tool accurately predicts risks of death, complications from obesity and diabetes

UM launches CAR-T clinical trial for patients with myasthenia gravis

Bariatric surgery lowers diabetic kidney disease risk for severely obese teens with type 2 diabetes

Teenage a time of sexual confusion, finds new study

Novel detection method for retinoblastoma

Penn researchers tag CAR T cells with imaging markers to monitor cancer therapy

Study identifies pretreatment change trajectories in people seeking treatment for AUD

Study highlights role of mind-body therapies in addressing opioid-treated pain

Researchers identify potential drug targets for glioblastoma

Tumor cell plasticity counts during cancer metastasis

HIMC at Mount Sinai to evaluate therapeutic effects of novel cancer immunotherapy

Dog ownership could lead to significant reduction in loneliness

MD Anderson and Takeda announce agreement to develop off-the-shelf CAR NK-cell therapy platform

FDA keeps brand-name drugs on a fast path to market ― despite manufacturing concerns

Signs of frailty could be identified through a new assessment

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News